Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Hematology · GATA2 Deficiency

The Biology and Diagnosis of GATA2 Deficiency

At a Glance

GATA2 deficiency results from a pathogenic change in the GATA2 gene that can disrupt blood-cell production, immunity, and lymphatic development. Diagnosis uses low blood counts and germline testing, sometimes from a non-blood sample to distinguish a lifelong variant from an acquired blood mutation.

Emberger syndrome is a specific form of GATA2 deficiency, a condition that disrupts how the body builds blood, immune cells, and the lymphatic system [1][2]. To understand this diagnosis, it helps to look at it as an error in a single gene that has several different jobs.

The Genetic “Master Switch”

The root cause of Emberger syndrome is a pathogenic variant in the GATA2 gene [3]. You can think of this gene as a master switch that tells the body how to develop Hematopoietic Stem Cells—the “seed” cells in the bone marrow that grow into all your different types of blood and immune cells [4][5].

When this switch is impaired (a state called haploinsufficiency), the body doesn’t produce enough of these cells, or the cells it does produce don’t work correctly [6]. This same gene is also involved in lymphatic development, which is why its disruption can lead to leg swelling (lymphedema) [7].

Inheritance: How It Happens

Emberger syndrome is an autosomal dominant condition [8]. This means a person only needs one copy of the mutated gene to have the syndrome. There are two ways this might happen:

  1. Inherited: One parent carries the mutation. Each pregnancy has a 50% chance of inheriting the pathogenic variant.
  2. De Novo: The mutation happens for the first time in the child, and neither parent has it in their blood [9].

Because of the inheritance patterns, genetic counseling is an essential part of care, helping you understand the implications and reproductive choices.

Diagnostic Findings in the Blood

When doctors suspect Emberger syndrome, they look for a very specific, though variable, pattern in the blood and bone marrow. This pattern is often the first “clue” before genetic testing is done.

  • Monocytopenia: This is a severe and persistent shortage of monocytes, a type of white blood cell that helps fight viruses and certain bacteria [3][10].
  • B-cell and NK-cell Lymphopenia: These are shortages of B cells (which make antibodies) and Natural Killer (NK) cells (which attack infected or cancerous cells) [11][12]. B-cell levels are often especially low in GATA2 deficiency [10].
  • Dendritic Cell Deficiency: These cells act like “scouts” for the immune system; without them, the body may not recognize an infection quickly enough [13].

The Definitve Test: Germline Genetic Testing

While blood counts provide clues, a pathogenic or likely pathogenic germline variant in the GATA2 gene supports a diagnosis of Emberger syndrome [14]. This test looks for the specific mutation in the DNA.

It is important that the test is “germline,” meaning it tests the DNA the person was born with. Sometimes, if a patient already has a blood disorder like MDS, a standard blood test might pick up a mutation that was acquired later in life rather than one they were born with. Furthermore, an ordinary cheek swab may contain blood cells. To confirm a germline mutation, genetics laboratories often require a non-hematopoietic sample, such as cultured skin fibroblasts from a skin biopsy, interpreted by a clinical geneticist [15][16].

Variable Penetrance: Why Every Case is Different

One of the most confusing parts of Emberger syndrome is variable penetrance. This means that even if two people have the exact same GATA2 mutation, their symptoms can be completely different [17].

  • Incomplete Penetrance: Some people carry the mutation but never get sick, or only develop minor symptoms later in life [17].
  • Variable Expressivity: Within the same family, one person might have severe hearing loss and early MDS, while a sibling or parent with the same mutation might only have minor lymphedema or slightly low blood counts [18][1].

Because of this, doctors strongly recommend testing all “first-degree” relatives (parents and siblings) of a person who is diagnosed [17]. This is especially important if a family member is being considered as a bone marrow donor, as they must not carry the pathogenic variant even if they seem perfectly healthy [19][20].

Monitoring for Changes

The bone marrow in people with GATA2 deficiency can be “unstable.” Over time, the marrow may become hypocellular (meaning it has fewer cells than normal) or start to show signs of Myelodysplastic Syndrome (MDS) [3][21]. Doctors monitor for specific chromosomal changes—like monosomy 7 (missing one of the number 7 chromosomes)—which can be a signal that the condition is progressing [14][22]. Regular monitoring allows the medical team to assess if and when treatments are needed.

Common questions in this guide

What is GATA2 deficiency, and how is it related to Emberger syndrome?
GATA2 deficiency is a genetic condition caused by a harmful change in the GATA2 gene. Emberger syndrome is a form of GATA2 deficiency that can affect blood-cell production, immune defenses, and lymphatic development, leading to problems such as low blood counts and lymphedema.
How is GATA2 deficiency diagnosed?
Doctors may first notice persistent low levels of monocytes, B cells, natural killer cells, or dendritic cells in blood testing. Diagnosis is supported by finding a pathogenic or likely pathogenic GATA2 variant with germline testing, which checks the DNA a person was born with.
Why might GATA2 testing require a skin sample instead of blood?
If a person has a blood disorder such as myelodysplastic syndrome, blood may contain a GATA2 change acquired later rather than the change present from birth. A cheek swab can also contain blood cells, so a laboratory may use cultured skin fibroblasts from a skin biopsy to confirm a germline result.
Can GATA2 deficiency be passed down in families?
Yes. It is autosomal dominant, so a person needs one altered copy of GATA2, and a parent who carries the variant has a 50% chance of passing it on in each pregnancy. The variant can also arise for the first time in a child, even when neither parent carries it in their blood.
Should healthy relatives be tested for a GATA2 mutation?
Testing of first-degree relatives, such as parents and siblings, is generally recommended because they may carry the variant without obvious symptoms. Testing can guide health monitoring and is especially important before considering someone as a bone marrow donor.
What blood or bone marrow changes can occur with GATA2 deficiency?
Common clues include a persistent shortage of monocytes and low B-cell and natural killer-cell levels; dendritic cells may also be missing or reduced. Over time, the bone marrow may have too few cells or develop myelodysplastic syndrome, and a missing copy of chromosome 7, called monosomy 7, can signal progression.
Why can people with the same GATA2 mutation have different symptoms?
Variable penetrance means some people with the same GATA2 variant never develop illness or have symptoms only later. Variable expressivity means affected relatives can have very different findings, such as hearing loss, lymphedema, low blood counts, or early myelodysplastic syndrome.

Get notified when new evidence is published on Deafness-lymphedema-leukemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    GATA 2 Deficiency: Focus on Immune System Impairment.

    Fabozzi F, Mastronuzzi A, Ceglie G, et al.

    Frontiers in immunology 2022; (13()):865773 doi:10.3389/fimmu.2022.865773.

    PMID: 35769478
  2. 2

    The different faces of GATA2 deficiency: implications for therapy and surveillance.

    Vinci L, Strahm B, Speckmann C, Erlacher M

    Frontiers in oncology 2024; (14()):1423856 doi:10.3389/fonc.2024.1423856.

    PMID: 38993648
  3. 3

    Germline GATA2 Mutation and Bone Marrow Failure.

    McReynolds LJ, Calvo KR, Holland SM

    Hematology/oncology clinics of North America 2018; (32(4)):713-728 doi:10.1016/j.hoc.2018.04.004.

    PMID: 30047422
  4. 4

    Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.

    Wu Z, Gao S, Diamond C, et al.

    Blood advances 2020; (4(12)):2656-2670 doi:10.1182/bloodadvances.2019001352.

    PMID: 32556286
  5. 5

    GATA2 deficiency and related myeloid neoplasms.

    Wlodarski MW, Collin M, Horwitz MS

    Seminars in hematology 2017; (54(2)):81-86 doi:10.1053/j.seminhematol.2017.05.002.

    PMID: 28637621
  6. 6

    Impaired DNA damage responses and inflammatory signaling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency.

    Abdelfattah A, Habib A, Thomas LA, et al.

    Stem cell reports 2025; (20(8)):102596 doi:10.1016/j.stemcr.2025.102596.

    PMID: 40749668
  7. 7

    GATA2 is required for lymphatic vessel valve development and maintenance.

    Kazenwadel J, Betterman KL, Chong CE, et al.

    The Journal of clinical investigation 2015; (125(8)):2979-94.

    PMID: 26214525
  8. 8

    GATA2 deficiency syndrome: A decade of discovery.

    Homan CC, Venugopal P, Arts P, et al.

    Human mutation 2021; (42(11)):1399-1421 doi:10.1002/humu.24271.

    PMID: 34387894
  9. 9

    GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.

    Brambila-Tapia AJL, García-Ortiz JE, Brouillard P, et al.

    Hematology (Amsterdam, Netherlands) 2017; (22(8)):467-471 doi:10.1080/10245332.2017.1294551.

    PMID: 28271814
  10. 10

    Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

    Nováková M, Žaliová M, Suková M, et al.

    Haematologica 2016; (101(6)):707-16 doi:10.3324/haematol.2015.137711.

    PMID: 27013649
  11. 11

    Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

    Schlums H, Jung M, Han H, et al.

    Blood 2017; (129(14)):1927-1939 doi:10.1182/blood-2016-08-734236.

    PMID: 28209719
  12. 12

    GATA2 regulates dendritic cell differentiation.

    Onodera K, Fujiwara T, Onishi Y, et al.

    Blood 2016; (128(4)):508-18 doi:10.1182/blood-2016-02-698118.

    PMID: 27259979
  13. 13

    Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages.

    Avagyan S, Weber MC, Ma S, et al.

    Blood advances 2021; (5(13)):2673-2686 doi:10.1182/bloodadvances.2020002992.

    PMID: 34170284
  14. 14

    The spectrum of GATA2 deficiency syndrome.

    Calvo KR, Hickstein DD

    Blood 2023; (141(13)):1524-1532 doi:10.1182/blood.2022017764.

    PMID: 36455197
  15. 15

    Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

    Calugaru OT, Coriu D, Jardan C, et al.

    Frontiers in medicine 2026; (13()):1935947 doi:10.3389/fmed.2026.1935947.

    PMID: 42750708
  16. 16

    Clinical relevance of mosaic variants detected by exome sequencing.

    Ghosh R, Fazal Z, Oler AJ, et al.

    The Journal of allergy and clinical immunology 2026; (157(5)):1195-1205 doi:10.1016/j.jaci.2026.02.011.

    PMID: 41724404
  17. 17

    Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.

    Oleaga-Quintas C, de Oliveira-Júnior EB, Rosain J, et al.

    Journal of clinical immunology 2021; (41(3)):639-657 doi:10.1007/s10875-020-00930-3.

    PMID: 33417088
  18. 18

    High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency.

    Ellingford JM, Telford N, Urquhart J, et al.

    Cancer genetics 2021; (256-257()):77-80 doi:10.1016/j.cancergen.2021.04.002.

    PMID: 33957466
  19. 19

    Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia.

    Heropolitańska-Pliszka E, Piątosa B, Szmydki-Baran A, et al.

    Frontiers in immunology 2022; (13()):928529 doi:10.3389/fimmu.2022.928529.

    PMID: 35983050
  20. 20

    Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.

    Kallen ME, Dulau-Florea A, Wang W, Calvo KR

    Seminars in hematology 2019; (56(1)):69-82 doi:10.1053/j.seminhematol.2018.05.016.

    PMID: 30573048
  21. 21

    MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.

    McReynolds LJ, Yang Y, Yuen Wong H, et al.

    Leukemia research 2019; (76()):70-75 doi:10.1016/j.leukres.2018.11.013.

    PMID: 30578959
  22. 22

    GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.

    Rajput RV, Arnold DE

    Current hematologic malignancy reports 2023; (18(4)):89-97 doi:10.1007/s11899-023-00695-7.

    PMID: 37247092

This page explains GATA2 deficiency and Emberger syndrome for informational purposes only and does not constitute medical advice. A hematologist, clinical geneticist, or genetic counselor should interpret your results and advise you about family screening.

Guide contents Deafness-lymphedema-leukemia syndrome
Research & Literature
01 Understanding Emberger Syndrome (GATA2 Deficiency) 03 Symptoms, Infections, and Warning Signs